⌘K

Home/Filings/4/0000875320-25-000057

4//SEC Filing

Ambrose Kristen 4

Accession 0000875320-25-000057

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:04 PM ET

Size

4.7 KB

Accession

0000875320-25-000057

Insider Transaction Report

Form 4

Period: 2025-02-12

VERTEX PHARMACEUTICALS INC / MAVRTX

Ambrose Kristen

SVP & Chief Accounting Officer

Transactions

Award
Common Stock
2025-02-12+2,080→ 12,033 total

Footnotes (1)

[F1]Restricted stock unit award that vests in installments beginning on 02/24/2026.

Documents

1 file

4
wk-form4_1739567081.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001856587

Filing Metadata

Form type: 4
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 4:04 PM ET
Size: 4.7 KB

View on SEC.gov